|
Volume 2 (2005), Issue 1 (January)
- Real-world clinical practice of intracoronary radiation therapy as compared to investigational trials.
Catheter Cardiovasc Interv, 64(1): 61-6. [Abstract] [Full-text]
- Minimizing urinary bladder radiation dose during brachytherapy for carcinoma of the cervix using balloon inflation technique.
Int J Radiat Oncol Biol Phys, 61(1): 257-66. [Abstract] [Full-text]
- Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets.
Int J Radiat Oncol Biol Phys, 61(1): 239-49. [Abstract] [Full-text]
- Quantification of shape variation of prostate and seminal vesicles during external beam radiotherapy.
Int J Radiat Oncol Biol Phys, 61(1): 228-38. [Abstract] [Full-text]
- Impact of tumor repopulation on radiotherapy planning.
Int J Radiat Oncol Biol Phys, 61(1): 220-7. [Abstract] [Full-text]
- ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer.
Int J Radiat Oncol Biol Phys, 61(1): 196-202. [Abstract] [Full-text]
- Repeat radiosurgery for idiopathic trigeminal neuralgia.
Int J Radiat Oncol Biol Phys, 61(1): 192-5. [Abstract] [Full-text]
- Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial.
Int J Radiat Oncol Biol Phys, 61(1): 185-91. [Abstract] [Full-text]
- Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience.
Int J Radiat Oncol Biol Phys, 61(1): 169-74. [Abstract] [Full-text]
- Analysis of axillary coverage during tangential radiation therapy to the breast.
Int J Radiat Oncol Biol Phys, 61(1): 163-8. [Abstract] [Full-text]
- Factors associated with the frequency of self-intermittent catheterization after prostate brachytherapy.
Int J Radiat Oncol Biol Phys, 61(1): 60-3. [Abstract] [Full-text]
- Dosimetry and cancer control after low-dose-rate prostate brachytherapy.
Int J Radiat Oncol Biol Phys, 61(1): 52-9. [Abstract] [Full-text]
- Randomized trial of high- and low-source strength (125)I prostate seed implants.
Int J Radiat Oncol Biol Phys, 61(1): 44-51. [Abstract] [Full-text]
- Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy.
Int J Radiat Oncol Biol Phys, 61(1): 32-43. [Abstract] [Full-text]
- The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24.
Am J Ophthalmol, 138(6): 936-51. [Abstract] [Full-text]
- Radiotherapy: what can be achieved by technical improvements in dose delivery?
Lancet Oncol, 6(1): 51-8. [Abstract] [Full-text]
- Sexual function after permanent 125I-brachytherapy for prostate cancer.
Int J Impot Res, 17(1): 96-101. [Abstract] [Full-text]
- Complications of radiation therapy on the brain and spinal cord.
Semin Neurol, 24(4): 405-17. [Abstract] [Full-text]
- Neurological manifestations of neoplastic and radiation-induced plexopathies.
Semin Neurol, 24(4): 385-93. [Abstract] [Full-text]
- The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations.
N Engl J Med, 352(2): 146-53. [Abstract] [Full-text]
- Gamma knife treatment for refractory cluster headache: prospective open trial.
J Neurol Neurosurg Psychiatry, 76(2): 218-21. [Abstract] [Full-text]
- Synthesis and in vivo biodistribution of BPA-Gd-DTPA complex as a potential MRI contrast carrier for neutron capture therapy.
Bioorg Med Chem, 13(3): 735-43. [Abstract] [Full-text]
- Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence: part I-lymphoma.
Cancer, 103(2): 383-92. [Abstract] [Full-text]
- Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence: part II-leukemia and myeloma.
Cancer, 103(2): 393-401. [Abstract] [Full-text]
- Cost comparison of surgery vs organ preservation for laryngeal cancer.
Arch Otolaryngol Head Neck Surg, 131(1): 21-6. [Abstract] [Full-text]
- Improvement of colonic healing by preoperative rectal irrigation with short-chain fatty acids in rats given radiotherapy.
Dis Colon Rectum, 47(12): 2184-94. [Abstract] [Full-text]
- Outcome of salvage abdominoperineal resection after failed endocavitary radiation in patients with rectal cancer.
Dis Colon Rectum, 47(12): 2039-46. [Abstract] [Full-text]
- Synthesis of new bivalent peptides for applications in the Affinity Enhancement System.
Bioconjug Chem, 16(1): 184-93. [Abstract] [Full-text]
- Role of biotin-binding affinity in streptavidin-based pretargeted radioimmunotherapy of lymphoma.
Bioconjug Chem, 16(1): 131-8. [Abstract] [Full-text]
- Donut-shaped high-dose configuration for proton beam radiation therapy.
Strahlenther Onkol, 181(1): 49-53. [Abstract] [Full-text]
- Radiobiological investigation of dose-rate effects in intensity-modulated radiation therapy.
Strahlenther Onkol, 181(1): 42-8. [Abstract] [Full-text]
- Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer.
Strahlenther Onkol, 181(1): 26-34. [Abstract] [Full-text]
- Phase I/II trial of simultaneous whole-brain irradiation and dose-escalating topotecan for brain metastases.
Strahlenther Onkol, 181(1): 20-5. [Abstract] [Full-text]
- Waiting for radiotherapy a national call for ethical discourse on waiting lists in radiotherapy: findings from a preliminary survey.
Strahlenther Onkol, 181(1): 9-19. [Abstract] [Full-text]
- Partial breast irradiation after breast-conserving surgery.
Strahlenther Onkol, 181(1): 1-8. [Abstract] [Full-text]
- Low-dose total body irradiation causes clonal fluctuation of primate hematopoietic stem and progenitor cells.
Blood, 105(3): 1010-5. [Abstract] [Full-text]
- Surgical results in pediatric Spetzler-Martin grades I-III intracranial arteriovenous malformations.
Childs Nerv Syst, 21(1): 69-74; discussion 75-6. [Abstract] [Full-text]
- Application of targeted radiotherapy/gene therapy to bladder cancer cell lines.
Eur Urol, 47(2): 250-6. [Abstract] [Full-text]
- Comparison of radiation dose estimation for myeloablative radioimmunotherapy for relapsed or recurrent mantle cell lymphoma using (131)I tositumomab to that of other types of non-Hodgkin's lymphoma.
Cancer Biother Radiopharm, 19(6): 738-45. [Abstract] [Full-text]
- Isolated tongue tremor after gamma knife radiosurgery for acoustic schwannoma.
Mov Disord, 20(1): 108-11. [Abstract] [Full-text]
- Intracranial meningioma and ionizing radiation in medical and occupational settings.
Neurology, 64(2): 350-2. [Abstract] [Full-text]
- Interactively exploring optimized treatment plans.
Int J Radiat Oncol Biol Phys, 61(2): 570-82. [Abstract] [Full-text]
- Image-guided radiotherapy for prostate cancer by CT-linear accelerator combination: prostate movements and dosimetric considerations.
Int J Radiat Oncol Biol Phys, 61(2): 561-9. [Abstract] [Full-text]
- Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer.
Int J Radiat Oncol Biol Phys, 61(2): 420-5. [Abstract] [Full-text]
- A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
Int J Radiat Oncol Biol Phys, 61(2): 400-8. [Abstract] [Full-text]
- Radiologic findings in patients treated with boron neutron capture therapy for glioblastoma multiforme within EORTC trial 11961.
Int J Radiat Oncol Biol Phys, 61(2): 392-9. [Abstract] [Full-text]
- Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial.
Int J Radiat Oncol Biol Phys, 61(2): 374-9. [Abstract] [Full-text]
- Axillary lymph node dose with tangential breast irradiation.
Int J Radiat Oncol Biol Phys, 61(2): 358-64. [Abstract] [Full-text]
- Dosimetric and clinical predictors for radiation-induced esophageal injury.
Int J Radiat Oncol Biol Phys, 61(2): 335-47. [Abstract] [Full-text]
- Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
Int J Radiat Oncol Biol Phys, 61(2): 318-28. [Abstract] [Full-text]
- Comparison of late rectal toxicity from conventional versus three-dimensional conformal radiotherapy for prostate cancer: analysis of clinical and dosimetric factors.
Urology, 65(1): 114-9. [Abstract] [Full-text]
- Influence of body mass index on biochemical outcome after permanent prostate brachytherapy.
Urology, 65(1): 95-100. [Abstract] [Full-text]
- Clinical effects of flurbiprofen tooth patch on radiation-induced oral mucositis. A pilot study.
Support Care Cancer, 13(1): 42-8. [Abstract] [Full-text]
- Optimal scheduling to reduce morbidity of involved field radiotherapy with transplantation for lymphomas: a prospective Australasian Leukaemia and Lymphoma Group Study.
Bone Marrow Transplant, 35(3): 291-8. [Abstract] [Full-text]
- Surgical resection and whole brain radiation therapy versus whole brain radiation therapy alone for single brain metastases.
Cochrane Database Syst Rev. [Abstract] [Full-text]
- Brachytherapy of vestibular schwannomas: report of three cases.
Minim Invasive Neurosurg, 47(6): 382-5. [Abstract] [Full-text]
- LINAC radiosurgery in skull base meningiomas.
Minim Invasive Neurosurg, 47(6): 333-8. [Abstract] [Full-text]
- Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer.
J Thorac Cardiovasc Surg, 129(2): 261-7. [Abstract] [Full-text]
- Dendrimers and dendritic polymers in drug delivery.
Drug Discov Today, 10(1): 35-43. [Abstract] [Full-text]
- Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer.
J Clin Oncol, 23(4): 826-31. [Abstract] [Full-text]
- Gamma knife radiosurgery for cavernous sinus plasmacytoma in a patient with breast cancer history.
Surg Neurol, 63(2): 174-6; discussion 176-7. [Abstract] [Full-text]
- Efficacy and safety of tositumomab and iodine-131 tositumomab (Bexxar) in B-cell lymphoma, progressive after rituximab.
J Clin Oncol, 23(4): 712-9. [Abstract] [Full-text]
© 2004-2008 Radiotherapy Research Today. All Rights Reserved.
|
|